TENAX THERAPEUTICS, INC. Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock
TENAX THERAPEUTICS, INC. (TENX) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock of 191.93 thousand shares for the 12-month period ending 2013-04-30, per its 10-K filed 2013-06-26.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock · last filed 2013-06-26
- TENAX THERAPEUTICS, INC. incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2013 was 191.93K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 12 month |
|---|---|
| 2013-04-30 | 191.93K shares 10-K · filed 2013-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |